Dr Marc POIROT will attend the annual meeting of the American Association for Cancer Research (AACR) in Washington, DC (USA) (April 17-21, 2010).
Dr Marc POIROT will give a talk entitled : “Molecular identification of the Cholesterol-5,6-Epoxide Hydrolase : a new target for selective estrogen receptor modulators and unsaturated fatty acids”.

New publications:

Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
de Medina P, Paillasse MR, Payré B, Silvente-Poirot S, Poirot M.
J Med Chem, 52, 7765-7777, dec. 2009.

Science-Business eXchange 2, (Published online Oct. 1 2009)
SciBX 2(38); doi:10.1038/scibx.2009.1451 Distillery: Therapeutics
http://www.nature.com/scibx/journal/v2/n38/full/scibx.2009.1451.pdf


AFFINSPI project

Français 
Dendrogenin - Biomarker - Drug design - Anticancer therapy - Cell differentiation - Receptor - Enzyme - Metabolism - Cancer - Deafness - Deafness - Melanoma - Neurodegenerative disease - Medicinal chemistry - Biotechnology - First in class molecule - New Chemical Entities - Cholesterol - Tamoxifen - Immunotherapy - Exosome - Oncology - Dendritic cell - Theranostic - Diagnosis - Prognosis -